A detailed history of Klingman & Associates, LLC transactions in Dario Health Corp. stock. As of the latest transaction made, Klingman & Associates, LLC holds 17,850 shares of DRIO stock, worth $14,280. This represents 0.0% of its overall portfolio holdings.

Number of Shares
17,850
Previous 17,850 -0.0%
Holding current value
$14,280
Previous $21,000 9.52%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 03, 2023

BUY
$3.53 - $5.49 $11,324 - $17,611
3,208 Added 21.91%
17,850 $76,000
Q1 2022

May 06, 2022

BUY
$5.84 - $13.61 $85,509 - $199,277
14,642 New
14,642 $86,000

Others Institutions Holding DRIO

About DarioHealth Corp.


  • Ticker DRIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 23,295,000
  • Market Cap $18.6M
  • Description
  • DarioHealth Corp. operates as a digital therapeutics company in the United States, Canada, the European Union, Australia, and New Zealand. The company offers Dario's metabolic solutions to address metabolic health needs, such as diabetes, hypertension, and weight management; Dario Musculoskeletal, which helps to prevent and treat the most common...
More about DRIO
Track This Portfolio

Track Klingman & Associates, LLC Portfolio

Follow Klingman & Associates, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Klingman & Associates, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Klingman & Associates, LLC with notifications on news.